Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amiodarone 75mg/5ml oral liquid
0203020D0AABJBJ
|
Amiodarone hydrochloride | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Amiodarone 80mg/5ml oral liquid
0203020D0AABQBQ
|
Amiodarone hydrochloride | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Amiodarone 85mg/5ml oral liquid
0203020D0AACDCD
|
Amiodarone hydrochloride | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Amisulpride 12.5mg/5ml oral liquid
0402010A0AAAJAJ
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
|
Amisulpride 200mg/5ml oral solution
0402010A0AAAMAM
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
|
Amisulpride 50mg/5ml oral liquid
0402010A0AAACAC
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
|
Amitiza 24microgram capsules
0106070C0BBAAAA
|
Amitiza | Lubiprostone | Gastro-Intestinal System | No data available |
|
Amitriptyline 1.25mg/5ml oral solution
0403010B0AABGBG
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 100mg/5ml oral solution
0403010B0AAA2A2
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 10mg / Perphenazine 2mg tablets
0403010B0AAA9A9
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 150mg/5ml oral solution
0403010B0AABFBF
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 15mg/5ml oral solution
0403010B0AABEBE
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 2.5mg/5ml oral solution
0403010B0AABBBB
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 2% / Ketamine 1% cream
100302000AAADAD
|
Generic compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Amitriptyline 25mg / Perphenazine 2mg tablets
0403010B0AAA8A8
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 25mg modified-release capsules
0403010B0AAAAAA
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 25mg/5ml oral suspension
0403010B0AAA5A5
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 50mg modified-release capsules
0403010B0AAABAB
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 5mg/5ml oral liquid
0403010B0AABDBD
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 75mg/5ml oral solution
0403010B0AAA1A1
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amitriptyline 80mg/5ml oral solution
0403010B0AAA7A7
|
Amitriptyline hydrochloride | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Amix 125 oral suspension
0501013B0BFAGAS
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 capsules
0501013B0BFAEAA
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 oral suspension
0501013B0BFAIAT
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 500 capsules
0501013B0BFAFAB
|
Amix | Amoxicillin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.